Other Meetings

International Cytokine & Interferon Society (ICIS) Symposium – Emerging Roles of Type III Interferons in COVID-19, Gut Microbiome, Adaptive Immunity, and Anti-Fungal Immunity

Thursday, May 13, 2021 5:00 PM ET – 7:00 PM ET

International Cytokine and Interferon Society (ICIS) Symposium
Emerging Roles of Type III Interferons in COVID-19, Gut Microbiome, Adaptive Immunity, and Anti-Fungal Immunity
Chairs:
Ludmila Prokunina-Olsson, NCI, NIH
Sergei V. Kotenko, Rutgers Univ.
Speakers:
Kristin A. Hogquist, Univ. of Minnesota, Distinct roles for type I and III interferons in thymic selection
Megan T. Baldridge, Washington Univ. Sch. of Med., Restriction of intestinal viral cellular tropism by IFN-λ
Amariliz Rivera, Rutgers Univ., Novel insights on IFN-λ in innate anti-fungal immunity
Ivan Zanoni, Harvard Med. Sch., Impact and regulation of type III interferon production in COVID-19
Ludmila Prokunina-Olsson, NCI, NIH, Type III interferon and the genetics of COVID-19 [READ MORE]

Other Meetings

EMDS 2021: 34th Annual Conference: Macrophages and dendritic cells in infection and inflammation, Virtual Meeting June 24-25

EMDS 2021
Due to the Covid-19 pandemic preventing us to meet in person, the 34th EMDS conference has been converted into an online meeting.
The Abstract submission portal is open. Deadline for submission of abstract: 30 April 2021.
Deadline for registration: 31 May 2021.
More Information: https://conferences.au.dk/EMDS/ [READ MORE]

Past Meetings

Cytokines 2021 Virtual Meeting

As communicated previously, the ever-changing uncertainties associated with the current pandemic has placed various pressures on the organization of our forthcoming Cytokines2021 meeting. After careful reflection, the ICIS has made the hard decision to transfer the annual meeting to a FULLY VIRTUAL conference. This decision will safeguard the health and wellbeing of our delegates and alleviate the stress related to the uncertainties of traveling and in-person gatherings. [READ MORE]

President's Letter

A NOTE FROM THE OUTGOING PRESIDENT, Kate Fitzgerald:

It has been an honor and privilege to serve as President of the ICIS. I want to express my gratitude to you all for your membership and the continued success of our conferences.
It has certainly been a unique time to lead the Society over the last two years. It seems in many ways, a seismic shift has occurred in all aspects of our lives, changing the way we live, work, and commune with each other. Yet despite the challenges, we see the progress and effectiveness of COVID-19 testing, vaccines that have been widely administered in the United States, Europe and around the world, and the hope of vaccines for young children and boosters on the horizon. The work of many of you has helped to continue to inform the response and treatments for this insidious virus. With variants continuing to surge, your work remains critically important as we continue to combat this and other emerging viruses in the future. [READ MORE]